Company intelligence / Profile preview

Sexton Biotechnologies

Indianapolis, Indiana, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Sexton Biotechnologies, founded in 2019 in Indianapolis, is a technology platform company providing cGMP-compatible manufacturing tools, automation systems, and media supplements (notably human platelet lysate) for the cell and gene therapy industry. Its technologies—such as the CellSeal platform, AF-500 fill/finish system, and Signata CT-5—enable standardized, automated, and scalable cell therapy production but Sexton does not develop its own therapeutic products. Sexton was acquired by BioLife Solutions in May 2021 for $24 million and continues operations as part of BioLife, retaining its Indianapolis base and team

Industry: Non-Drug Biotech

Partnerships

BioSpherix Medical (collaborative fill-finish system)Hitech Health and Med Institute (flexible automation partnership)CCMI Galway (regenerative medicine product manufacturing)Ikeda Scientific (human platelet lysate supply in Japan)

Beyond the preview

Go deeper on Sexton Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sexton Biotechnologies.

Explore the full profile